SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-042474
Filing Date
2021-08-13
Accepted
2021-08-13 16:06:12
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0621_chinapharmahold.htm   iXBRL 10-Q 636261
2 CERTIFICATION f10q0621ex31-1_chinapharma.htm EX-31.1 9932
3 CERTIFICATION f10q0621ex31-2_chinapharma.htm EX-31.2 9994
4 CERTIFICATION f10q0621ex32-1_chinapharma.htm EX-32.1 5223
  Complete submission text file 0001213900-21-042474.txt   3593958

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cphi-20210630.xsd EX-101.SCH 42106
6 XBRL CALCULATION FILE cphi-20210630_cal.xml EX-101.CAL 38413
7 XBRL DEFINITION FILE cphi-20210630_def.xml EX-101.DEF 179597
8 XBRL LABEL FILE cphi-20210630_lab.xml EX-101.LAB 348673
9 XBRL PRESENTATION FILE cphi-20210630_pre.xml EX-101.PRE 188261
10 EXTRACTED XBRL INSTANCE DOCUMENT f10q0621_chinapharmahold_htm.xml XML 333038
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

IRS No.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34471 | Film No.: 211172093
SIC: 2834 Pharmaceutical Preparations